Kainos Medicine, Inc. (KOSDAQ:284620)
1,152.00
-118.00 (-9.29%)
Last updated: Aug 13, 2025
Kainos Medicine Market Cap
Kainos Medicine has a market cap or net worth of 35.97 billion as of August 14, 2025. Its market cap has decreased by -71.03% in one year.
Market Cap
35.97B
Enterprise Value
36.31B
Revenue
820.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,152.00
Market Cap Chart
Since June 9, 2020, Kainos Medicine's market cap has decreased from 434.22B to 35.97B, a decrease of -91.72%. That is a compound annual growth rate of -38.17%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 13, 2025 | 39.44B | -55.85% |
Dec 30, 2024 | 89.33B | -25.94% |
Dec 28, 2023 | 120.62B | 5.37% |
Dec 29, 2022 | 114.48B | -59.11% |
Dec 30, 2021 | 279.94B | -40.72% |
Dec 30, 2020 | 472.24B | 8.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 464.35T |
SK hynix | 184.32T |
LG Energy Solution | 91.03T |
Samsung Biologics | 73.45T |
Hyundai Motor Company | 46.43T |
Hanwha Aerospace | 45.27T |
Doosan Enerbility | 44.45T |
HD Hyundai Heavy Industries | 41.19T |